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ABSTRACT: In this study, we aimed to use physicochemical
and theoretical tools to understand fundamental problems of
the interaction between lipid bilayers (Egg-PC liposomes) and
unmodified C60 fullerenes. The morphology, the size, and the
electrokinetic properties of plain and C60-loaded liposomes
were investigated by means of atomic force microscopy, dynamic
light scattering, and ζ-potential studies, respectively. The
incorporation of C60 molecules into the liposomes increases
their size; however, there was no effect on their electrokinetic
properties. Visualization studies revealed that the presence of
C60 in the membranes induced distortion in vesicle mor-
phology, resulting in nonspherical vesicles. To elucidate
further the impact of C60 molecules on lipid bilayers, we assessed their miscibility by fluorescence spectroscopy measurements.
Fluorescence measurements showed that the presence of C60 in liposomes causes a pronounced effect on the Nile red emission
spectrum due to alterations to the packing of the lipid membrane. The release of vesicle-encapsulated calcein was used as a
measure of the integrity of the liposomes. Plain liposomes were found to be more stable compared with C60-loaded (PC)
liposomes, suggesting that C60 ruptures the liposome membrane. Toxicity studies of C60 in liposomes were carried out on
cultured cells [rodent fibroblasts (3T3)] to assess further their toxicity. The results suggest that fullerene cytotoxic effect was
reduced significantly after its incorporation into the liposomal bilayer after 24 h of incubation with the rodent fibroblasts (3T3).
Finally, energy minimization studies were employed to underpin the experimental observations. The theoretical calculations
show that low concentration of fullerene molecules present in the membrane had no effect on the membrane integrity; however,
at high concentrations of fullerenes significant enlargement of the surface area is observed, supporting the experimental findings.
■ INTRODUCTION
Fullerenes have been used in several biological processes as
antioxidants in cosmetic products,1 drug carriers,2 or molecular
imaging probes.3 They have the ability to function as a free
radical sponge and quench various free radicals more efficiently
than conventional antioxidants4 and to migrate through the
entire body, including the blood-brain barrier, without
adsorbing serum proteins.5 However their poor water solubility
has severely limited their use in applications. An approach to
overcome this obstacle is the use of various amphiphilic
molecules6 including phospholipids.7 Moreover, the use of lipo-
somes might reduce the reported toxicity of these materials.8,9
Liposomes have been used widely as drug delivery systems. The
main advantages of liposomes as a drug delivery system are the
following: (i) they have a very versatile structure that can be
easily tailored to bear the properties needed for each specific
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application, (ii) they can accommodate any type of drug
molecules either in their aqueous compartments (hydrophilic
drugs) or in their bilayers (lipophilic drugs) or both (ampliplilic
drugs), and (iii) they are nontoxic, nonimmunogenic and fully
biodegradable.10 Studies of the interaction of lipid membranes
(liposomes) with fullerenes might provide insightful infor-
mation into phenomena like membrane fusion, channel
opening, and structural transitions that occur upon lipid−
fullerene interactions. Several studies have combined ful-
lerenes with lipid bilayers using both experimental11−18 and
theoretical approaches.19−22 However, little is known on the
effect of fullerenes or fullerene derivatives on the miscibility
of the liposomal membrane using experimental approaches23,24
and consequently the stability of fullerene-loaded lipo-
somes over time. In an attempt to shed light onto such interac-
tions, we investigated the effect of C60 on the membrane
integrity of PC liposomes combining experimental and theoretical
tools.
■ MATERIALS AND METHODS
Materials. Unmodified C60 fullerenes, calcein, Nile Red
(NR), and Triton X-100 were obtained from Sigma-Aldrich (U.K.).
Thiazolyl blue tetrazolium, Sephadex G-50 and buffer salts were
purchased from Sigma-Aldrich. The components used for cell
culture were from Gibco, U.K. L-α-Phosphatidylcholine (egg-PC)
was purchased from Avanti Lipids (Alabaster, AL). Organic
solvents were obtained from Fischer Scientific U.K. All solutions
were prepared by Millipore water (conductivity <0.5 μS·cm−1).
Preparation of the C60 Solution. A stock solution of C60
in CHCl3 with a final concentration of 0.2 mg/mL was pre-
pared by adding 2 mg of C60 to 10 mL of CHCl3. The dispersion
was subjected to sonication in a bath sonicator (Branson,
Danbury, CT) for 2 h until a brownish solution was obtained.
The solution remained stagnant for 2 weeks, and the amount
of the solubilized C60 was quantified by UV−vis spectroscopy
(Lambda 35; Perkin-Elmer, USA).
Liposome Preparation. Liposomes consisting of L-α-
phosphatidylcholine were prepared by the thin film method.
In brief, 6.5 μmol of PC and 0.15 μmol of C60 (molar ratio of
C60/PC: 2.3%) were dissolved in CHCl3 in a spherical flask,
and the organic solvent was removed in a rotary evaporator.
The film was rehydrated with 1 mL of PBS pH 7.4 and was
sonicated for 60 min in a bath sonicator. The amount of C60
encapsulated in the PC liposomes was determined by
measuring the residual free C60 as follows: The C60-containing
liposome suspension was loaded in a Sephadex G-50 (1 × 35 cm)
column equilibrated with PBS at pH 7.4. Presaturation of the
column was performed with the lipid. The final lipid concen-
tration was measured by using a phospholipid colorimetric assay.25
The nonencapsulated material that remained on the top of the
column7 was collected and mixed with 5 mL of CHCl3 to extract
the C60 and was further quantified by UV-spectroscopy.
Dynamic Light Scattering and ζ-Potential Studies.
The particle size was measured by dynamic light scattering
(DLS). Normalized intensity−time correlation functions g(2)(q,t) =
⟨I(q,t)I(q,0)⟩/⟨I(q,0)⟩2, were measured over a broad time scale
(from 10−7 to 104 s) using a full multiple tau digital correlator
(ALV-5000/FAST) with 280 channels spaced quasi-logarithmi-
cally. The scattering wavevector q = 4πn sin(θ/2)/λο depends
on the scattering angle θ (θ = 90ο was used in the present
work), the laser wavelength λο, and the refractive index of the
medium n. The 671 nm line from a diode pumped solid-state
laser was used in the present study operating at a power of
<5 mW. The scattered light was collected by a single-mode
optical fiber, which provided a high coherence factor (∼0.95)
and transferred to an avalanche photodetector and then to the
digital correlator for analysis. Accumulation times were on the
order of a few seconds because of the strong scattered intensity
from the depressions. Several time correlation functions were
recorded for each dispersion to check the reproducibility of the
results. Under the assumption of homodyne scattering
conditions, which are easily fulfilled in dilute suspensions as
in the present case, the desired normalized electric-field time
autocorrelation function
= ⟨ * ⟩ ⟨ ⟩g q t E q t E q E q( , ) ( , ) ( , 0) / ( , 0)(1) 2 (1)
is related to the experimentally recorded intensity autocorre-
lation function g(2)(q,t)2 through the Siegert relation26
= + *| |g q t B f g q t( , ) [1 ( , ) ](2) (1) 2 (2)
where B describes the long delay time behavior of g(2)(q,t) and
f* represents an instrumental factor obtained experimentally
from measurements of a dilute polystyrene/toluene solution. In
our case, the optical fiber collection results in f* ≈ 0.95.
The electric-field time correlation function g(1)(t) (for simplicity
we drop the q dependence in the following) was analyzed as a
weighted sum of independent exponential contributions, that is
∫ ∫= τ − τ τ = τ − τ τg t L t L t( ) ( ) exp( / ) d (ln ) exp( / ) d ln(1) (3)
where the second equality is the logarithmic representation
of the relaxation times. The distribution of relaxation times
L(ln τ) = τ L (τ) was obtained by the inverse Laplace transfor-
mation (ILT) of g(1)(q,t) using the CONTIN algorithm.27 The
apparent hydrodynamic radii of the suspended “particles” were
determined using the Stokes−Einstein relation
=
π
R
k T
nD6h
B
(4)
where kB is the Boltzmann constant, η is the viscosity of the
solvent, and D the particle self-diffusion coefficient. The latter is
determined by D = 1/τq2, where τ is the relaxation time of
g(1)(q,t). Electrophoretic measurements for the determination
of ζ-potential values of the suspensions were performed in a
Malvern Instrument Nano ZetaSizer (U.K.) equipped with a
4 mW He−Ne laser, operating at a wavelength of 633 nm and
having an avalanche photodiode as a detector. Data were
acquired with laser Doppler velocimetry and the phase analysis
light scattering (PALS) mode after equilibration at 25 °C.
Fluorescence Spectroscopy. Fluorescence measurements
were performed at 25 °C on a fluorescence spectrophotometer
(F2500; Hitachi, Japan) using a quartz cell with a light path of
10 mm. Specifically, 1.5 mL from the suspensions was placed in a
1 cm quartz cuvette and emission spectra were recorded at 90°
during excitation at 448 nm. For this purpose, a hydrophobic dye,
NR, was added in the liposomes at a concentration of 7.5 μM.
Visualization Studies. Surface topography images of plain-
and C60-loaded liposomes were obtained by means of atomic
force microscopy (AFM). A droplet of the liposomal
suspension was placed onto freshly cleaned mica and left for
several minutes to allow vesicles to adsorb onto the mica.
During this time, the extra water surrounding the adsorbed
vesicles was evaporated, leaving behind a thin water film, which
covered the sample. Following this, the sample was imaged
in tapping mode (in air) with the constant force method.
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(The force between the sample surface and the AFM tip was
kept constant by a feedback system while the surface beneath the
tip was scanned.) The samples were scanned with the minimum
possible image force to minimize the potential deformation of
the vesicle due to tip compression with the aid of MultiMode
Scanning Probe Microscopy (Veeco) using a Nanoscope IIIa
controller and a 120 μm × 120 μm magnet-free scanner (model
AS-130VMF) developed by Digital Instruments with vertical
range of 5 μm and a z-axis resolution of 0.05 nm. The scan rate
was 1 Hz. The cantilever’s spring constant was 10 N/m. The
shape of the silicon nitride tips was square pyramidal with
radius of curvature ∼10 nm and half angle ∼15°. The images
were processed with a linear plane fit to remove any sample tilt
on them. Final contrast/lighting adjustments of all images were
performed on Adobe Photoshop CS4.
Membrane Integrity Studies. The release of vesicle-
encapsulated calcein (100 mM) was determined with the
separation of free and liposomal dye, as reported elsewhere.28
The membrane integrity of liposomes after incubation in
buffer at 37 °C was evaluated by calculating the percentage of
calcein latency (%) of liposome-encapsulated calcein, as pre-
viously described.29 In brief, 10 μL was withdrawn from each
incubation tube and diluted with 4 mL of PBS, pH 7.40. The
fluorescence intensity of this sample was measured (Varian
Cary Eclipse U.S., emission 490 nm, excitation 520 nm) before
and after the addition of Triton X-100 at a final concentration
of 1% (v/v). The percentage of calcein latency (%) was
calculated using the following equation
= − ×F F
F
%latency 100T I
T (5)
where FI and FT are the calcein fluorescence of the sample in the
absence and presence of 1% Triton X-100 (final concen-
tration), respectively. These values, obtained after mixing the
samples with Triton X-100, were corrected accordingly for
dilution.
Proliferative Studies. Viability of 3T3 cells was evaluated
using the thiazolyl blue tetrazolium bromide (MTT) assay,
which is associated with cell mitochondrial activity. The assay is
based on the ability of viable cells to convert MTT solution to
blue formazan crystals in their mitochondria.30 Cells were
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum (FCS) at 37 °C in a
5% CO2 incubator. 3T3 cells were seeded at a concentration of
5 × 104 cells/mL/well in 24-well plates and left for 24 h to
adhere on the plates. Then, they were incubated with either
plain liposomes or free fullerenes or fullerene-loaded liposomes
at increasing concentrations for 1 day. The cells in the first
three wells were incubated in the absence of any of the
formulations. DMSO (0.5 mL/well) was used as positive
control for cell death. After 24 h of incubation, 100 μL of MTT
solution (concentration 5 mg/mL) was added to the wells and
incubated for 2 h at 37 °C. The blue formazan salts were
dissolved in 100 μL of acidified isopropanol (0.33 μL HCl in
100 mL of isopropanol), which was transferred to 96-well
plates, and the absorbance was read on a microplate reader
(Bio-Tec Instruments, U.S.) at wavelength of 490 nm. Viability
of the cells was calculated by comparing the number of viable cells
in the formulation-treated wells to the nonformulation treated cells.
Molecular Simulation Studies. Energy minimization
calculations were used to investigate the mode of insertion of
the C60 to the lipid bilayers. A simulated annealing protocol was
used prior to energy minimization to help ensure that a global
minimum energy was obtained. Simulations were carried out
using the CVFF forcefield as implemented in the Materials
Studio (v4.1, Accelrys Software, San Diego, CA),31 The CVFF
forcefield has been widely used to investigate successfully the
properties of phospholipid membranes.32−38 One advantage
of using this forcefield in this particular study is that a
consistent set of potentials could be used for the lipid bilayer
and the C60 molecules, with the (C = 2) parameter used for the
carbon atoms within the fullerene. The simulation box used for
the bilayer was constructed using two 4 × 4 arrays of PC
molecules. Initially, the dimensions of the box were 35 Å ×
30 Å × 120 Å, although the dimensions of the box were allowed
to vary throughout both the simulated annealing and the energy
minimization part of the simulation. Calculations were
performed in parallel on a 16 processor Linux cluster. Periodic
boundary conditions were applied to simulate an infinite array,
with Ewald summation used ensure appropriate treatment of
long-range electrostatic interactions. Water molecules were
added above and below the bilayer using the Soak algorithm. In
total, 5382 water molecules were included. The simulated
annealing routine involved slowly reducing the simulation
temperature of the system through temperatures of 750, 500,
300, and 100 K using molecular dynamics (MD) with a
simulation time of 10 ps at each temperature. Finally, energy
minimization using a combination of the steepest descents and
conjugate gradients methods was performed until the energy
derivative was <0.001 kcal mol−1 Å−1. Simulations were per-
formed with zero, two, and eight fullerene molecules placed
within the bilayer region.
■ RESULTS AND DISCUSSION
Solubilization of C60 in CHCl3 and Entrapment
Efficiency of Liposomes. Fullerenes were measured at
330 nm and the calibration curve was linear (r2 > 0.99) in the
range of 3.0−25.0 μg/mL in CHCl3 (A330 = −0.17338 + 0.0969
[C60], where [C60] is the concentration of C60 in μg/mL). The
amount of fullerene dissolved in the organic solvent was
estimated to be 0.117 mg/mL, which is in broad agreement
with the solubility values previously reported (solubility in
CHCl3 0.16 mg/mL).
39
The amount of C60 present in the membrane was calculated
indirectly by measuring the nonencapsulated material. The C60
content in the liposomes was found to be 30% or 0.045 μmoles
of the initial amount of C60 added to the liposomes.
Size Analysis and ζ-Potential Measurements. The DLS
evaluation of plain and C60-loaded liposomes in PBS pH 7.4
revealed a bimodal distribution for both plain and C60-loaded
liposomes (Figure 1). ILTs on the experimental data yield the
distributions of the hydrodynamic radii that for liposomes
exhibit two populations with average particle diameters of
146 ± 8 and 821 ± 35 nm, respectively. In a similar manner,
C60-loaded liposomes display two populations with average
particle diameter of 183 ± 11 and 1288 ± 50 nm, accordingly.
The significantly observed increase in C60-loaded liposomes
indicates the presence of C60 fullerenes in the lipid membrane
(t test p = 0.01, n = 3). However, it should be stressed that
Figure 1 illustrates the scattered intensity form of the ILT
distributions. Taking into account the dependence of the
scattered intensity on the sixth power of the particle size and
the difference between the sizes of the two populations in each
dispersion it is obvious that the population of large particles
is much smaller than that of the small ones. In particular, we
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estimate that the volume ratio of the small over the large
particles is ca. 15 and 150 for PC and C60-loaded PC
dispersions, respectively. There was no significant difference in
the ζ-potential values between the C60 liposomes (−1.52 ±
0.26 mV) and the plain ones (−1.03 ± 0.19 mV).
Miscibility Studies. The miscibility of C60 with PC
liposomes was assessed by means of fluorescence spectroscopy.
NR is a solvatochromic probe having a high affinity for
lipid molecules.40 The emission spectra of NR in plain and
C60-loaded liposomes are illustrated at Figure 2. Nonencapsulated
NR, plain PC, and C60-loaded liposomes were measured as
controls under the same conditions. No emission spectra could
be recorded for the controls, as illustrated in Figure 2. The
emission of NR incorporated into both plain and C60-loaded
liposomes exhibits a maximum at λ ≈ 615 nm. However the
fluorescence intensity in plain liposomes is higher, implying
that liposomes can accommodate higher numbers of NR
molecules compared to the C60-loaded PC liposomes. This
conclusion is based on the fact that the same amount of NR
was used in both plain and C60-loaded liposomes and that NR
when exposed to water experiences a dramatic decrease in its
fluorescence emission. Another possible cause for the decrease
in the fluorescence emission of NR in C60-loaded liposomes
could be the mere quenching of NR’s emission by the presence
of fullerenes. We investigated this by performing fluorescence
measurements on NR solutions with increasing amounts of C60
(data not shown). It was found that C60, even at concentrations
of 30 μg/mL (similar to that found in the liposomes dispersion
of Figure 2), decreases by only ∼15% the fluorescence intensity
of NR. This decrease is much lower than the 60% decrease
observed in Figure 2. A third possibility has to do with the fact
that if C60 and NR are both incorporated in the bilayer, then
C60’s relative concentration in the bilayer would be much higher
than 30 μg/mL, and thus quenching might be possible.
NR can penetrate into the liposome bilayer, thus being less
exposed to water. Therefore, according to the first explanation,
the lower fluorescence emission of NR in C60-loaded liposomes
indicates the expulsion of NR when C60 molecules are present
in the bilayer. The presence of C60 provides a lipid environment
with lower incorporation capacity; therefore, the model
compound is exposed to water.41 In conclusion, having rejected
the second possible cause for the fluorescence decrease and
based on the other two possibilities as explained in the para-
graph above, the experiment of Figure 2 suggests the incorpo-
ration of C60s in the bilayer membrane.
Visualization Studies. The AFM studies revealed that the
presence of fullerenes in the membranes induced considerable
distortion in vesicle morphology (Figure 3 B, bottom image).
The convex shape of both plain and C60-loaded liposomes
could be attributed to the tip compression force during imaging
as well in some point to the coupling of liposome with the mica.
Plain liposomes (Figure 3A upper image) show smooth
surface morphology, whereas the presence of fullerenes in the
membranes results in polyhedral-like vesicles (Figure 3B, face
indicated by a white arrow). This difference could also be
observed in cross-section profile analysis (right images). On
plain liposomes, the profile line appears as a smooth curve
whereas on PC-C60-loaded liposomes the profile line appears
“crooked” when crossing from one particle “side” to the other.
Moreover, “rod-like” structures (indicated by the blue arrow)
might be attributed to the presence of C60 molecules to the
membrane.
Liposome Stability Studies. The (%) latency of vesicle-
encapsulated calcein is used as a measure of membrane
integrity. From the results of these studies (Figure 4), it is clear
that the PC-liposomes are stable because after 24 h of
incubation, more than 68.57 ± 2.29% of the initially
encapsulated calcein is retained in the vesicles, in accordance
with previous studies.42 On the contrary, when C60 were
incorporated into the lipid bilayers, there is a pronounced effect
on the stability of PC liposomes because a rapid decrease in the
latency retention occurred within the first hour (from 75.27 ±
12.05 to 50.28 ± 3.9%), followed by a leveling off up to 24 h
Figure 1. Inverse Laplace transform analysis of the experimental time
correlation functions (eq 2) obtained by DLS for (a) plain and (b)
C60-loaded PC dispersions. Open circles: experimental data points.
Solid lines: best fit curve obtained by ILT (eq 3). Open diamonds and
squares: intensity distributions of the hydrodynamic diameters.
Average magnitudes of the hydrodynamic diameters estimated by
eq 4 are shown for each distribution.
Figure 2. Fluorescence spectra of Nile Red (NR) in neat PC and
PC-C60 liposomes, respectively. Data key presented in Figure inset.
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(t-test; p < 0.05). These preliminary results imply that ful-
lerenes destabilize the liposomal membrane over time. Previous
studies have shown that C60 molecules form aggregates into the
lipid membranes.7 In a previous study, the presence of C60 in
1-palmitoyl-2-oleoylphosphatidylcholine (POPC) large unilamelar
vesicles increased the stability of the liposomal membrane, as
shown by carboxyflouroscein (CF) retention studies. These
differences might be attributed to the different type of the lipid
and the temperature used for monitoring the release of CF.43
Very recently, in an experimental study Zupanc et al. showed
that C60 water suspension causes changes of the average mean
curvature of the lipid membrane, leading to the rupture of
POPC vesicles.44
Proliferative Studies. The effect of freshly prepared C60-
loaded liposomes, plain liposomes, and free C60 on 3T3 cell
activity was assessed using the MTT assay. It can be seen that
C60-loaded liposomes did not show any detrimental effect on
the 3T3 activity after 24 h of incubation (t test: p < 0.001)
(Figure 5 A). At least 50% of the initial amount of incorporated
fullerene is still retained in the formulation. Plain PC liposomes
did not affect the cell viability, as expected. Free fullerenes
significantly affected the cell activity at concentrations of either
100 μg/mL or equal to that contained in 400 μg/mL, as shown
in Figure 5B. The results suggest that the cytotoxic effect of
fullerene was reduced significantly after its incorporation into
the liposomal bilayer after 24 h of incubation with the rodent fibro-
blasts, at which fullerene toxicity depends on its derivatiza-
tion,45,46 the solvent it is dispersed in, and its solubility,47,48 con-
centration, size, and route of exposure.47 It has been reported
that the action of fullerene can be ambiguous as it is dose-
dependent. Therefore, fullerene can be beneficial at low dose as
a scavenger of reactive oxygen species and free radicals, thus
yielding an antitumor effect due to phototoxic reactions. C60
can be harmful at higher doses as it has been shown to cause
lipid peroxidation of cell membrane lipids, radical formation,
inflammation, and cancer.
The most prominent mechanism of fullerene cytotoxicity is
the production of reactive oxygen species and cell membrane
lipid peroxidation and necrotic cell death. However, Spohn
Figure 3. AFM images of (A) plain PC liposomes and (B) C60-loaded PC liposomes. Bars are 270 and 260 nm, respectively.
Figure 4. Calcein release (% of entrapped) from liposomes dispersed
in PBS buffer pH 7.4 during incubation for a total period of 24 h. Data
key presented in Figure inset (t test: p < 0.05).
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et al.47 showed that fullerene was not toxic toward the epithelial
cell line A549 after 6 days of incubation. On the contrary,
fullerene and its derivatives showed a profound difference
in cytotoxicity on various cell lines, as was shown by Sayes
et al.,49,50 who reported that LC50 varies from 2 to 50 μg/L for
neuronal human astrocytes and human liver carcinoma cells,
respectively, after 48 h of incubation. Our results agree with
those of Sayes et al.,49 but the effect of fullerene on cell viability
is in the ppm and not the ppb range as the authors have
reported. However, there are no data reported elsewhere on the
fullerene toxicity on 3T3 cells.
Molecular Simulation Studies. The structure of the lipid
and the carboanceous material is shown in Figure 6. The
optimized lipid bilayer in the absence of C60 is illustrated in
Figure 7A. An overview of the lipid bilayer viewed from the top
with the water molecules removed (for clarity) is shown in
Figure 7 B. At low concentrations of C60 (2 per simulation
box), the carbonaceous material is incorporated into the bilayer
toward the middle of the layer. This observation is inconsistent
with long MD simulations perfomed on C60 within a
phosphatidylcholine bilayer, supporting the validitiy of our
approach.20 When higher concentrations of fullerenes were
present in the liposomal bilayer, as illustrated in Figure 9A, the
C60 molecules are much more readily seen, suggesting that
significant disruption to the surface of the bilayer has occurred.
Figure 8 shows how the hydrophobic tails of the PC wrap
themselves around the C60 molecule to maximize the van der
Waals interactions. At this low concentration of C60 molecules,
no disruption of the surface of the bilayer is observed and the
Figure 5. (A) 3T3 cell proliferation after 24 h of incubation with either
plain PC liposomes or C60-loaded liposomes. (B) Comparison of cell
proliferation in the presence of the “empty” PC, C60-loaded PC
liposomes, free fullerenes (C60) at concentration equal to that
contained in 400 μg/mL, and free C60 after 24 h of incubation with
3T3 cells (t test: p < 0.001).
Figure 6. (a) Structure of phosphatidycholine and (b) fullerene.
Figure 7. (A) Optimized lipid bilayer without C60 molecules. (B)
Optimized phospholipid bilayer viewed from top (water molecules
removed for clarity).
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surface viewed from above (Figure 8B) appears similar to that
shown in Figure 7B, with the C60 molecule largely shielded
from view. The hydrophobic tails of the phospholipids again
“mold” themselves around fullerene molecules, but at higher
concentrations adjacent fullerenes are displaced higher up the
bilayer toward the hydrophilic head of the phospholipid
molecules (Figure 9B), thus disrupting the surface. This effect
is also reflected in the calculated size of the surface area for each
of the three simulations. At low concentration of fullerene
(2 molecules per simulation box) and with no fullerene present,
the surface area remains largely unchanged, with values of 840
and 835 Å2 obtained, respectively.
However, at the higher concentration of fullerene (eight
molecules per simulation box), the surface area increases
significantly to 1003 Å2, reinforcing the suggestion that low
quantities of fullerene have little effect on the surface of the
bilayer but that high concentrations can disrupt it substantially.
At both concentrations, incorporation of the fullerene into
the bilayer results in a favorable binding energy (−261 and
−289 kcal mol−1 at low and high concentrations, respectively),
although we note that the binding energy per C60 molecule is
higher at low concentration (−131 kcal mol−1) than at high
concentration (−36 kcal mol−1). The theoretical observations
in this work are supported by our experimental measurements
that show that the lipid membrane becomes “leaky” at high
loading of C60 and provide a clear rationale for this observation.
■ CONCLUSIONS
Toward the understanding of the interactions between lipid
bilayers with unmodified C60, a combination of experimental
and theoretical techniques have been employed to assess the
stability and the integrity of the lipid membrane.
The fluorescence spectroscopy studies have confirmed the
miscibility of the fullerenes with the lipid bilayer. AFM imaging
has shown that the presence of fullerenes in the membrane
induce structural changes within the produced vesicles in PBS,
the biological relevant medium used in this study. Integrity
studies revealed that the incorporation of C60 molecules can
Figure 8. (A) Optimized lipid bilayer with two C60 molecules per
simulation box. The one C60 molecule visible in this orientation is
shown in light blue. (B) Optimized phospholipid bilayer viewed from
the top (water molecules removed for clarity).
Figure 9. (A) Optimized lipid bilayer with eight C60 molecules per
simulation box. The C60 molecules visible in this orientation are shown
in light blue. (B) Optimized phospholipid bilayer viewed from the top
(water molecules removed for clarity).
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induce disruption of the membrane based on the retention values
of the hydrophilic marker calcein. The fullerene cytotoxic effect
was reduced significantly after its incorporation into the liposomal
bilayer after 24 h of incubation with the rodent fibroblasts miti-
gating the risk for their use to biomedical applications. Finally, the
experimental data are corroborated by the theoretical calculations
where high concentrations of fullerenes to the membrane induce
disruption to the surface, which is not the case for low concen-
tration of fullerene as the membrane remains intact.
On the basis of the data presented in the current study, it can
be anticipated that the amount of C60 present in the membrane
is directly linked to its integrity; therefore, studies varying the
concentration of fullerenes up to the saturation of the mem-
brane and the type of liposomes in terms of size and lamellarity
can offer insight into the stability of these dispersions and
therefore lay the frame for future work.
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